Rudolf Magnus Institute of Neurosciences, Department of Rehabilitation, Physical Therapy Science & Sports, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Department of General Practice, Erasmus MC, Rotterdam, The Netherlands.
Arch Phys Med Rehabil. 2018 Aug;99(8):1609-1622.e10. doi: 10.1016/j.apmr.2018.03.003. Epub 2018 Apr 5.
To present an evidence-based overview of the effectiveness of oral pain medication and corticosteroid injections to treat carpal tunnel syndrome (CTS).
The Cochrane Library, PubMed, Embase, CINAHL, and Physiotherapy Evidence Database were searched for relevant systematic reviews and randomized controlled trials (RCTs).
Two reviewers independently applied the inclusion criteria to select potential studies.
Two reviewers independently extracted the data on pain (visual analog scale), function or recovery, and assessed the methodologic quality.
A best-evidence synthesis was performed to summarize the results of the included studies. Four reviews and 9 RCTs were included. For oral pain medication, strong and moderate evidence was found for the effectiveness of oral steroids versus placebo in the short term. Moderate evidence was found in favor of oral steroids versus splinting in the short term. No evidence was found for the effectiveness of oral steroids in the long term. For corticosteroid injections, strong evidence was found in favor of a corticosteroid injection versus a placebo injection and moderate evidence was found in favor of corticosteroid injection versus oral steroids in the short term. Also, in the short term, moderate evidence was found in favor of a local versus a systematic corticosteroid injection. Higher doses of corticosteroid injections seem to be more effective in the midterm; however, the benefits of corticosteroid injections were not maintained in the long term.
The reviewed evidence supports that oral steroids and corticosteroid injections benefit patient with CTS particularly in the short term. Although a higher dose of steroid injections seems to be more effective in the midterm, the benefits of oral pain medication and corticosteroid injections were not maintained in the long term.
对口服止痛药和皮质类固醇注射治疗腕管综合征(CTS)的有效性进行基于证据的综述。
对 Cochrane 图书馆、PubMed、Embase、CINAHL 和物理治疗证据数据库进行了检索,以查找相关的系统评价和随机对照试验(RCT)。
两名审查员独立应用纳入标准选择潜在的研究。
两名审查员独立提取疼痛(视觉模拟评分)、功能或恢复的数据,并评估方法学质量。
进行最佳证据综合以总结纳入研究的结果。共纳入 4 项综述和 9 项 RCT。对于口服止痛药,在短期治疗中,口服皮质类固醇与安慰剂相比具有较强和中等的疗效证据。在短期治疗中,与夹板相比,口服皮质类固醇具有中等的疗效证据。在长期治疗中,没有发现口服皮质类固醇有效的证据。对于皮质类固醇注射,有强有力的证据表明皮质类固醇注射优于安慰剂注射,有中等强度的证据表明皮质类固醇注射优于口服皮质类固醇在短期治疗中。此外,在短期治疗中,局部皮质类固醇注射优于系统性皮质类固醇注射,也有中等强度的证据支持。皮质类固醇注射的较高剂量在中期似乎更有效;然而,皮质类固醇注射的益处并未在长期维持。
综述证据支持口服皮质类固醇和皮质类固醇注射对 CTS 患者特别在短期有益。尽管较高剂量的类固醇注射在中期似乎更有效,但口服止痛药和皮质类固醇注射的益处并未在长期维持。